BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34586368)

  • 1. Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes.
    Jung HH
    JAMA Netw Open; 2021 Sep; 4(9):e2127387. PubMed ID: 34586368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal fasting glucose levels with regard to cardiovascular and mortality outcomes in people treated with or without antidiabetic medication.
    Jung HH; Lee S
    Diabetes Obes Metab; 2020 Feb; 22(2):243-253. PubMed ID: 31602755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.
    Afkarian M; Zelnick LR; Hall YN; Heagerty PJ; Tuttle K; Weiss NS; de Boer IH
    JAMA; 2016 Aug; 316(6):602-10. PubMed ID: 27532915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
    Mottl AK; Buse JB; Ismail-Beigi F; Sigal RJ; Pedley CF; Papademetriou V; Simmons DL; Katz L; Mychaleckyj JC; Craven TE
    Clin J Am Soc Nephrol; 2018 Nov; 13(11):1693-1702. PubMed ID: 30361335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes.
    Kaze AD; Jaar BG; Fonarow GC; Echouffo-Tcheugui JB
    BMC Med; 2022 Mar; 20(1):127. PubMed ID: 35346165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study.
    Kim C; Ricardo AC; Boyko EJ; Christophi CA; Temprosa M; Watson KE; Pi-Sunyer X; Kalyani RR;
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1171-1180. PubMed ID: 30398516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death.
    Elsayed EF; Sarnak MJ; Tighiouart H; Griffith JL; Kurth T; Salem DN; Levey AS; Weiner DE
    Am J Kidney Dis; 2008 Jul; 52(1):29-38. PubMed ID: 18511168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.
    Cooper ME; Perkovic V; McGill JB; Groop PH; Wanner C; Rosenstock J; Hehnke U; Woerle HJ; von Eynatten M
    Am J Kidney Dis; 2015 Sep; 66(3):441-9. PubMed ID: 25960304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unrecognized prevalence of chronic kidney disease in diabetes.
    Middleton RJ; Foley RN; Hegarty J; Cheung CM; McElduff P; Gibson JM; Kalra PA; O'Donoghue DJ; New JP
    Nephrol Dial Transplant; 2006 Jan; 21(1):88-92. PubMed ID: 16221715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
    Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
    J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.